Here are 8 best practices for enhancing diversity and inclusion in your clinical trials.
Our NOWINCLUDED platform boasts about 100,000 engaged persons of color, providing a unique and representative sample for engagement.
With Acclinate's proven recruitment strategies, a recent study achieved a 400% increase in self-identified, pre-screened persons of color.
Out of the 400% increase in pre-screened persons of color in our latest study, 40% expressed willingness to participate.
Acclinate is dedicated to promoting diversity and representation in clinical trials through our NOWINCLUDED platform and sustained engagement tactics. We empower communities of color to make informed health decisions and connect pharma with individuals willing to participate in clinical trials. As a leader in this field, we do not recruit individuals for trials; instead, we access, engage, and mobilize communities of color.
Through our community engagement platform, NOWINCLUDED™, we empower and inform minority communities by providing access to relevant health-related content sourced from experts. Our platform serves as a hub for connection and shared perspectives, stories, and insights among members of the minority community.
We actively engage with underrepresented communities through online and offline channels, such as community activation points. These points of connection include trusted individuals and organizations with credibility in communities of color, including elected officials, healthcare providers, HBCU presidents, faith-based organizations, and sororities/fraternities.
Together, we are working towards greater representation and inclusion in clinical research.
At Acclinate, we understand the importance of collaboration and partnership in achieving our mission of promoting diversity and representation in clinical research.
We partner with leading CROs, DCTs, and Patient Engagement firms to provide innovative engagement services and predictive analytics software, e-DICT. Our cutting-edge technology helps pharmaceutical companies and health organizations identify and precisely target likely participants for their clinical research, resulting in more efficient recruitment, lower costs, and increased diverse enrollment.